Cathie Wood’s ARK buys Palantir stock, sells AMD shares By Investing.com

ARK’s daily trading update showed a net shift toward Palantir Technologies, with 85,485 shares purchased for about $11.15 million, while 44,446 AMD shares were sold for $10.52 million. ARK also trimmed Strata Critical Medical by 75,389 shares, worth $305,325, continuing recent divestment. The piece is primarily a flow/positioning update rather than fundamental news, so the likely market impact is modest.

Analysis

This flow is more informative as a positioning signal than a fundamentals signal. The incremental buying into PLTR suggests ARK is leaning harder into the “sovereign AI / data platform” trade while simultaneously fading a higher-beta semiconductor name that has already rerated on AI enthusiasm; that usually matters most at the margin when growth factors are crowded and investors are rotating within the AI complex rather than exiting it. In other words, the message is not “AI is dead,” but “enterprise software with embedded AI monetization may have a cleaner next leg than hardware after the first valuation expansion.”

The AMD reduction could pressure the near-term AI semi basket because active growth managers often reinforce each other’s factor exposures. If other momentum funds interpret this as a signal to de-risk AI hardware, semis with the weakest near-term earnings revision support are most vulnerable first, while names with secular software attach rates and lower capex intensity can absorb that capital more easily. The second-order effect is a relative-value setup: hardware may lag even if the broader AI theme holds, especially over the next 2-6 weeks if markets stay range-bound and flows matter more than fundamentals.

SRTA’s ongoing liquidation is a signal of low conviction, not a macro read, but it matters because forced or persistent seller behavior in small caps tends to create air pockets that can persist for weeks. The contrarian angle on PLTR is that crowding risk is rising: when a stock becomes the preferred expression of a thematic allocator, upside can continue, but drawdowns become sharper if the next catalyst disappoints or if rates back up. The cleanest way to frame this is that ARK is expressing a preference for software-duration over hardware-cyclicality; if that’s right, the market should keep rewarding names with visible recurring revenue and penalizing names reliant on a second-half cyclical inflection.

Key Decisions for Investors

• Long PLTR / short AMD for 2-6 weeks as a relative-value expression of software-duration over hardware-cycle exposure; target a 5-8% spread capture, cut if AMD regains leadership on strong revision data.
• Buy PLTR call spreads into weakness over the next 1-3 trading sessions to express continued AI-software momentum with defined risk; structure for 2:1 to 3:1 payoff if the stock re-rates on flow continuation.
• Fade the weakest AI semi names via a basket short against QQQ or SMH if semiconductor breadth deteriorates further; the trade works best if rates are stable and factor rotation stays inside AI rather than broader tech.
• Avoid bottom-fishing SRTA until forced selling abates; this is a liquidity-driven tape where the first bounce is often just supply being reloaded, not a fundamental inflection.
• If PLTR gaps up on continued flow support, take partial profits into strength rather than chasing size; crowding risk is the main near-term downside catalyst.